ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy and Safety Study of Aplindore in Patients With Early Parkinson Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00809302
Recruitment Status : Terminated (Neurogen acquired by Ligand Pharmaceuticals - no further support for study. No safety concerns identified.)
First Posted : December 17, 2008
Last Update Posted : August 28, 2009
Sponsor:
Information provided by:
Neurogen Corporation

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Estimated Primary Completion Date : August 2009
  Estimated Study Completion Date : October 2009